Sign inGet started

Reilly Thomas Charles

Insider CIK 1827590 · CARA Chief Financial Officer · AMRN SVP and CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AMRN AMARIN CORP PLC\UK M Exercise deriv2024-07-012024-07-0116,667— $016,666SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2024-07-012024-07-0116,667— $0102,514SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2024-07-012024-07-018,209$0.69 $5.7K94,305SEC↗
AMRN AMARIN CORP PLC\UK M Exercise deriv2024-06-202024-06-2133,333— $033,333SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2024-06-202024-06-2133,333— $0102,264SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2024-06-202024-06-2116,417$0.73 $12.0K85,847SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2024-02-012024-02-09418,000— $0418,000SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2024-02-012024-02-09116,000— $0116,000SEC↗
AMRN AMARIN CORP PLC\UK M Exercise deriv2024-01-312024-02-0244,933— $089,867SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2024-01-312024-02-0244,933— $093,483SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2024-01-312024-02-0224,552$1.24 $30.4K68,931SEC↗
AMRN AMARIN CORP PLC\UK M Exercise deriv2024-01-102024-01-1251,500— $00SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2024-01-102024-01-1251,500— $00SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2024-01-102024-01-1228,325$0.97 $27.5K48,550SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2024-01-102024-01-1251,500— $076,875SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2023-07-192023-07-21404,400$1.08 $436.8K404,400SEC↗
AMRN AMARIN CORP PLC\UK M Exercise deriv2023-07-012023-07-0516,667— $033,333SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2023-07-012023-07-058,209$1.19 $9.8K25,375SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2023-07-012023-07-0516,667— $033,584SEC↗
AMRN AMARIN CORP PLC\UK M Exercise deriv2023-06-202023-06-2233,334— $066,666SEC↗
AMRN AMARIN CORP PLC\UK M Exercise2023-06-202023-06-2233,334— $033,334SEC↗
AMRN AMARIN CORP PLC\UK F Tax w/h2023-06-202023-06-2216,417$1.19 $19.5K16,917SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2023-02-212023-02-2350,000— $050,000SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2023-02-212023-02-23269,600— $0269,600SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2023-02-212023-02-23134,800— $0134,800SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2022-07-012022-07-06100,000— $0100,000SEC↗
AMRN AMARIN CORP PLC\UK A Award deriv2022-07-012022-07-06100,000— $0100,000SEC↗
CARA Cara Therapeutics, Inc. S Sale2022-03-032022-03-042,044$11.38 $23.3K37,811SEC↗
CARA Cara Therapeutics, Inc. A Award2022-02-282022-03-015,333$10.29 $54.9K39,855SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2022-02-252022-03-0140,000— $040,000SEC↗
CARA Cara Therapeutics, Inc. A Award2022-02-252022-03-0120,000— $034,522SEC↗
CARA Cara Therapeutics, Inc. A Award2021-12-172021-12-2111,170— $014,522SEC↗
CARA Cara Therapeutics, Inc. S Sale2021-08-302021-09-011,982$14.20 $28.1K3,352SEC↗
CARA Cara Therapeutics, Inc. A Award2021-08-242021-08-265,334— $05,334SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2020-10-012020-10-07175,000— $0175,000SEC↗